» Articles » PMID: 34832512

Hepatomegaly Associated with Non-Obstructive Sinusoidal Dilation in Experimental Visceral Leishmaniasis

Overview
Journal Pathogens
Date 2021 Nov 27
PMID 34832512
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Visceral leishmaniasis (VL) is the most severe form of leishmaniasis caused by protozoan parasites of the genus . Hepatomegaly is one of the most frequent clinical manifestations of VL, whereas immunopathology of the symptom has not been well investigated. Using our chronic model of experimental VL, we examined the influence of infection on the liver by clinical, histological, and biochemical analyses. The infected mice showed increased liver weight 24 weeks post-infection. Although an increase in serum ALT and inflammatory cell accumulation were observed in the livers of infected mice, no apparent parenchymal necrosis or fibrosis was observed. Tissue water content analyses demonstrated that increased liver weight was predominantly due to an increase in water weight. Together with the finding of hepatic sinusoidal dilation, these results suggested that edema associated with sinusoidal dilation causes hepatomegaly in infection. Immunostaining of platelets and erythrocytes showed no thrombus formation or damage to the sinusoidal endothelium in the liver of infected mice. Taken together, these results suggest that hepatomegaly during experimental VL is caused by non-obstructive sinusoidal dilation.

Citing Articles

Nicotinamide mitigates visceral leishmaniasis by regulating inflammatory response and enhancing lipid metabolism.

Zhou Q, Zheng Z, Yin S, Duan D, Liao X, Xiao Y Parasit Vectors. 2024; 17(1):288.

PMID: 38971783 PMC: 11227177. DOI: 10.1186/s13071-024-06370-x.


Visceral leishmaniasis as a rare cause of granulomatous hepatitis.

Ben Sabbahia D, Atrassi M, Msaaf H, Chahid I, Khoaja A, Bennani N JPGN Rep. 2024; 5(2):200-203.

PMID: 38756116 PMC: 11093897. DOI: 10.1002/jpr3.12059.


SIV Infection Is Associated with Transient Acute-Phase Steatosis in Hepatocytes In Vivo.

Derby N, Biswas S, Yusova S, Luevano-Santos C, Pacheco M, Meyer K Viruses. 2024; 16(2).

PMID: 38400071 PMC: 10892327. DOI: 10.3390/v16020296.


Vaccination with Formulation of Nanoparticles Loaded with Leishmania amazonensis Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster.

Gonzalez M, Goncalves A, Ottino J, Leite J, Resende L, Melo-Junior O Vaccines (Basel). 2023; 11(1).

PMID: 36679956 PMC: 9863486. DOI: 10.3390/vaccines11010111.

References
1.
Salguero F, Garcia-Jimenez W, Lima I, Seifert K . Histopathological and immunohistochemical characterisation of hepatic granulomas in Leishmania donovani-infected BALB/c mice: a time-course study. Parasit Vectors. 2018; 11(1):73. PMC: 5793367. DOI: 10.1186/s13071-018-2624-z. View

2.
Mandarim-de-Lacerda C . Stereological tools in biomedical research. An Acad Bras Cienc. 2003; 75(4):469-86. DOI: 10.1590/s0001-37652003000400006. View

3.
Queiroz M, Alves J, Correia J . [Visceral leishmaniasis: clinical and epidemiological features of children in an endemic area]. J Pediatr (Rio J). 2004; 80(2):141-6. View

4.
Duarte M, Corbett C . Histopathological patterns of the liver involvement in visceral leishmaniasis. Rev Inst Med Trop Sao Paulo. 1987; 29(3):131-6. DOI: 10.1590/s0036-46651987000300003. View

5.
Marzano C, Cazals-Hatem D, Rautou P, Valla D . The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome. Hepatology. 2015; 62(3):956-63. DOI: 10.1002/hep.27747. View